Study Summary
A Study of CD 70 CAR T for patients with CD70 positive malignant hematologic diseases
Want to learn more about this trial?
Request More InfoInterventions
CD70 CAR T-cellsBIOLOGICAL
Each subject receive CD70 CAR T-cells by intravenous infusion
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| The first affiliated hospital of medical college of zhejiang university | Hangzhou | Zhejiang | China |